BMRN vs RCUS · P/E 40, rev $1.76B vs rev $58.0M
Biomarin Pharmaceutical Inc (BMRN) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported RCUS revenue for 2026-06-30 was $58.0M. Net income was -$219.0M. RCUS currently screens at market cap $885.2M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the BMRN and RCUS stock pages for the full models.
Not investment advice.